Bio Impact Capital LLC Axsome Therapeutics, Inc. Transaction History

Bio Impact Capital LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$65.72 - $80.5 $1.2 Million - $1.46 Million	18,185 Added 15.93%	132,312 $10.7 Million
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $1.44 Million - $2.03 Million	20,740 Added 22.21%	114,127 $9.11 Million
Q4 2023 Feb 13, 2024	SELL	$57.42 - $83.61 $11,426 - $16,638	-199 Reduced 0.21%	93,387 $7.43 Million
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $1.35 Million - $2.09 Million	23,184 Added 32.93%	93,586 $6.73 Million
Q1 2023 May 12, 2023	BUY	$58.39 - $75.0 $1.08 Million - $1.38 Million	18,427 Added 35.45%	70,402 $4.34 Million
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $2.08 Million - $4.14 Million	51,975 New	51,975 $4.01 Million
Q2 2022 Aug 11, 2022	SELL	$21.74 - $46.75 $2.17 Million - $4.67 Million	-99,834 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$23.7 - $41.39 $84,632 - $147,803	-3,571 Reduced 3.45%	99,834 $4.13 Million
Q4 2021 Feb 11, 2022	SELL	$30.7 - $43.36 $207,225 - $292,680	-6,750 Reduced 6.13%	103,405 $3.91 Million
Q3 2021 Nov 15, 2021	BUY	$19.91 - $68.26 $2.19 Million - $7.52 Million	110,155 New	110,155 $3.63 Million

327

38M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.56B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Bio Impact Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Bio Impact Capital LLC with notifications on news.